Vitrolife AB (VITR)

Currency in SEK
146.00
+9.00(+6.57%)
Real-time Data·
VITR Scorecard
Full Analysis
Has raised its dividend for 3 consecutive years
Unusual trading volume
Earnings results expected in 0 days
VITR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
140.80148.00
52 wk Range
126.30252.60
Key Statistics
Prev. Close
137
Open
142
Day's Range
140.8-148
52 wk Range
126.3-252.6
Volume
217.46K
Average Volume (3m)
88.77K
1-Year Change
-41.15%
Book Value / Share
98.07
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VITR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
199.25
Upside
+36.47%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Vitrolife AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Vitrolife AB Company Profile

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Employees
1147
Market
Sweden

Vitrolife AB Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of SEK 0.74 missed forecast by 33.33%, revenue fell 7% YoY to SEK 871M, stock dropped 6.68%
  • 3% organic growth in local currencies excluding discontinued ops; gross margin declined to 58% from 59.9% YoY
  • U.S. IVF market faces regulatory challenges; company optimistic about EMEA and Americas performance
  • CEO: U.S. patients postponing, not canceling IVF; expects government intervention to support declining birth rates
  • Cautious outlook for APAC market; monitoring potential government support for IVF, especially in U.S.
Last Updated: 17/07/2025, 10:10
Read Full Transcript

Compare VITR to Peers and Sector

Metrics to compare
VITR
Peers
Sector
Relationship
P/E Ratio
40.8x−19.6x−0.7x
PEG Ratio
0.36−0.370.00
Price/Book
1.4x10.3x2.6x
Price / LTM Sales
5.2x51.6x3.4x
Upside (Analyst Target)
38.6%40.7%37.6%
Fair Value Upside
Unlock10.7%5.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 199.25
(+36.47% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.35%
Dividend Yield
0.80%
Industry Median 1.59%
Annualised payout
1.10
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 17, 2025
EPS / Forecast
0.74 / 1.11
Revenue / Forecast
871.00M / 886.70M
EPS Revisions
Last 90 days

VITR Income Statement

People Also Watch

343.9
NOVOb
-6.05%
63.60
TEPRF
-0.59%
273.50
SAND
+0.11%
198.50
MYCR
-1.46%

FAQ

What Stock Exchange Does Vitrolife Trade On?

Vitrolife is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Vitrolife?

The stock symbol for Vitrolife is "VITR."

What Is the Vitrolife Market Cap?

As of today, Vitrolife market cap is 19.76B.

What Is Vitrolife's Earnings Per Share (TTM)?

The Vitrolife EPS (TTM) is 3.35.

When Is the Next Vitrolife Earnings Date?

Vitrolife will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is VITR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Vitrolife Stock Split?

Vitrolife has split 1 times.

How Many Employees Does Vitrolife Have?

Vitrolife has 1147 employees.

What is the current trading status of Vitrolife (VITR)?

As of 17 Oct 2025, Vitrolife (VITR) is trading at a price of 146.00, with a previous close of 137.00. The stock has fluctuated within a day range of 140.80 to 148.00, while its 52-week range spans from 126.30 to 252.60.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.